Infant, Child, and Maternal Probiotic Supplements Market to 2028

Infant, Child, and Maternal Probiotic Supplements Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Form (Capsules and Softgels, Gummies, Liquid, and Others) and End User (Infant and Toddler, Children, and Maternal Women)

Publication Month: Jul 2022 | Report Code: TIPRE00029530 | No. of Pages: No. of Pages130 | Category: Food and Beverages | Status: Published

The infant, child, and maternal probiotic supplements market is projected to reach US$ 1,081.70 million by 2028 from US$ 604.94 million in 2021. It is expected to grow at a CAGR of 8.7% from 2022 to 2028.

Probiotics are live bacteria and/or yeast, which benefit the person's gut health. Various benefits of probiotic supplements include boosting the gut microbiome, restoring balance to the microbiome, and supporting the immune system. Such benefits have surged its use among the target audience, which includes infants, children, and maternal women. Parents are increasingly focusing on their child’s nutrition and well-being, driving the market. Also, the increasing adoption of probiotic supplements among pregnant women has boosted the market substantially. Constant R&D taking place in this category across the globe will uplift the market growth in the coming years

In 2020, North America held the largest share of the global infant, child, and maternal probiotic supplements market, and Asia Pacific is estimated to register the fastest CAGR during the forecast period. Rising population, economic development, and an increase in disposable income are some factors contributing to the market's growth. Population in emerging economies, such as India, China, and Japan, are adopting nutritional supplements to improve the growth and development of children. Moreover, the increased infant mortality rate in emerging economies has fueled the demand for probiotic supplements in the region. For instance, according to the World Bank, in 2020, the infant mortality rate in East Asia Pacific was 11 per 1,000 live births.

Strategic Insights

Report CoverageDetails
Market Size Value inUS$ 604.94 Million in 2021
Market Size Value byUS$ 1,081.70 Million by 2028
Growth rateCAGR of 8.7% from 2022 to 2028
Forecast Period2022-2028
Base Year2021
No. of Pages130
No. of Tables44
No. of Charts & Figures61
Historical data availableYes
Segments coveredForm, and End User
Regional scopeNorth America; Europe; Asia Pacific; Latin America; MEA
Country scopeUS, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available

Impact of COVID-19 Pandemic on Infant, Child, and Maternal Probiotic Supplements Market

Before the onset of the COVID-19 pandemic, the infant, child, and maternal probiotic supplements market was mainly driven by the rising focus of parents on specific infant nutrition and the increasing demand for nutritional supplements tailored according to the needs of pregnant women. However, the market faced unprecedented challenges after the outbreak in 2020. Manufacturers of infant, child, and maternal probiotic supplements faced significant challenges due to supply chain constraints caused by nationwide lockdowns, trade bans, and travel restrictions. Supply chain disruptions created a shortage of raw materials, which affected the production and distribution of various products, leading to increased prices.

In 2021, various economies resumed operations as governments announced relaxation in the previously imposed restrictions, which boosted the global market. Moreover, production facilities were permitted to operate at full capacity, which helped them overcome the demand and supply gap and other repercussions. As numerous citizens of many countries were fully vaccinated by 2021, market players focused on increasing their production to revive their businesses.

Infant, Child, and Maternal Probiotic Supplements Market Breakdown, by Region

Infant, Child, and Maternal Probiotic Supplements Market Breakdown, by Region

Get more information on this report :

Market Insights

Growing Awareness Regarding Benefits of Probiotic Supplements among Pregnant Women to Drive Infant, Child, and Maternal Probiotic Supplements Market

Probiotics lower the risk of pre-eclampsia in pregnant women, a health condition resulting in high blood pressure and high protein levels in urine. Probiotic supplements also ensure better immunity for pregnant women, which helps fight chronic diseases and ensure the baby's good health. Lactobacillus acidophilus, Bifidobacterium bifidum, and Saccharomyces boulardii are among the most effective and widely used probiotic strains in prenatal probiotic supplements. These strains help to maintain a healthy intestinal flora and reduce the risk of various allergies, diseases, and complications, including gestational diabetes and pre-eclampsia. The growing awareness about the benefits of probiotic supplements among pregnant women is substantially driving the infant, child, and maternal probiotic supplements market.

Form Insights

Based on form, the infant, child, and maternal probiotic supplements market is categorized into capsules and softgels, gummies, liquid, and others . The others segment held the largest share in the market during the forecast period. However, the gummies segment is expected to register the highest CAGR during the forecast period. Sweet and easy-to-consume probiotic gummies are available in appealing colors and shapes (such as teddy bears) and various flavors. Several manufacturers are engaged in product innovations to meet the growing demands of adults and children. Such strategic developments by manufacturers to diversify their product range is likely to propel the demand for infant, child, and maternal probiotic supplement gummies in the coming years.

Infant, Child, and Maternal Probiotic Supplements Market, by From – 2021 and 2028

Infant, Child, and Maternal Probiotic Supplements Market, by From – 2021 and 2028

Get more information on this report :

End User Insights

Based on End User, the infant, child, and maternal probiotic supplements market is segmented into infants and toddlers, children, and maternal women. The children segment accounted for the largest market share in 2020. Probiotic supplements are gaining popularity in these children as they play a vital role in relieving colic, acute constipation, and acid reflux. Some researchers have shown that probiotics can help prevent antibiotic-related diarrhea in children, so pediatricians often include probiotic supplements while prescribing antibiotics.

Major players operating in the infant, child, and maternal probiotic supplements market include Bayer Corporation; Nestle S.A.; Mommy’s Bliss Inc.; LoveBug Probiotics; BioGaia AB; MaryRuth Organics, LLC; Pharmavite LLC; Evolve Biosystems; Biomeology; and Nordic Naturals. These companies are emphasizing on new product launches and geographical expansions to meet the growing consumer demand worldwide. They have a widespread global presence, which provides them to serve a large set of customers from all over the world and subsequently increases their market share. These market players focus heavily on new product launches and regional expansions to increase their product range in specialty portfolios.

Report Spotlights

  • Progressive industry trends in the infant, child, and maternal probiotic supplements market to help companies develop effective long-term strategies
  • Business growth strategies adopted by the infant, child, and maternal probiotic supplements market players in developed and developing countries
  • Quantitative analysis of the market from 2020 to 2028
  • Estimation of global demand for workwear
  • Porter’s Five Forces analysis to illustrate the efficacy of buyers and suppliers in the Infant, Child, and Maternal Probiotic Supplements Market
  • Recent developments to understand the competitive market scenario
  • Market trends and outlook, as well as factors driving and restraining the growth of the Infant, Child, and Maternal Probiotic Supplements Market
  • Assistance in the decision-making process by highlighting market strategies that underpin commercial interest
  • Size of the infant, child, and maternal probiotic supplements market at various nodes
  • A detailed overview and workwear industry dynamics
  • Size of the infant, child, and maternal probiotic supplements market in various regions with promising growth opportunities

Frequently Asked Questions

The major players operating in the global infant, child, and maternal probiotic supplements market are Bayer Corporation; Nestle S.A.; Mommy’s Bliss Inc.; LoveBug Probiotics; Biogaia AB; MaryRuth Organics, LLC; Pharmavite LLC; Evolve Biosystems; Biomeology; and Nordic Naturals.
Infant nutrition is one of the most lucrative markets in Asia Pacific. The rising population, steady economic development, and increase in per capita income are some of the major factors driving the infant nutrition market. People in countries such as China, India, and South Korea are highly concerned about their children's health and wellbeing and are widely adopting dietary supplements that support their growth and development. Infant probiotic supplements are also gaining significant traction, owing to children and infants' rising focus on digestive health and immunity. Thus, the rising demand for infant probiotic supplements in developing markets is expected to provide lucrative growth opportunities over the forecast period.
Based on form, others segment mainly has the largest revenue share. The other forms in the segment include powder, tablets, chewable tablets, effervescent tablets, lozenges, and quick dissolvable formats. The growth is attributed by increasing use of these forms owing to their various benefits such as longer shelf life and physiochemical stability of powder, inexpensive, more effective, and among others. Moreover, such benefits offered by this form have surged manufacturers to in launching probiotic supplements in various forms such as lozenges.
North America accounted for the largest share of the global workwear market. North America is one of the most significant regions for the infant, child, and maternal probiotic supplements market due to the increasing awareness about the benefits offered by probiotic supplements in infants, children, and pregnant women. Parents in the region are more concerned about their children's development and growth. Some common health conditions observed in the region include allergies, asthma, urinary tract infection, colic in infants, and autism. According to the Allergy & Asthma Foundation of Asthma, in 2018, approximately 5.2 thousand children in the US were diagnosed with seasonal allergic rhinitis. Increasing health issues among children have concerned parents, which in turn, has resulted in the uptake of probiotic supplements.
Based on the end user, maternal women segment is projected to grow at the fastest CAGR over the forecast period. Probiotic supplements are gaining popularity among pregnant women owing to their role in reducing the risk of eczema in babies, lessening complications associated with childbirth, and improving the metabolic health of expectant mothers. Women experience dramatic changes in physiology and immune systems during pregnancy, including alterations in the gut microbiome population. These issues can be addressed using probiotic supplements. Probiotic supplements help pregnant women in gaining weight.
Of late, parents have become more concerned about specific nutrition for their children to ensure proper growth and development. According to the World Health Organization (WHO), providing proper nutrition to babies in their first 3 years can reduce mortality and morbidity in them, decrease the risk of chronic diseases throughout their lifetime, and promote regular mental and physical growth. The poor nutrition of infants can cause serious health issues, including stunted growth and malnutrition. Additionally, poor nutrition during the first 3 months of a baby's life can increase the risk of death. However, the rise in awareness regarding proper infant nutrition among parents has reduced the infant mortality rate. Therefore, increase in awareness regarding such nutritional intake has surged the demand for infant, child, and maternal probiotic supplements market.

The List of Companies - Infant, Child, and Maternal Probiotic Supplements Market

  1. Bayer Corporation
  2. Nestle S.A.
  3. Mommy’s Bliss Inc.
  4. LoveBug Probiotics
  5. Biogaia AB
  6. MaryRuth Organics, LLC
  7. Pharmavite LLC
  8. Evolve Biosystems
  9. Biomeology
  10. Nordic Naturals
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global infant, child, and maternal probiotic supplements market, thereby allowing players to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth the market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation, and industry verticals.
TIPRE00029530
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




Have a question?

Shejal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount